Living on the Spectrum cover
Living on the Spectrum

Living on the Spectrum

About

A public-facing conversational podcast exploring autism, ADHD, Sensory Processing Disorder (SPD), Developmental Language Disorder (DLD), and other neurodevelopmental differences. We curate the latest findings from research and community discussions, turning complex information into clear, dual-host dialogues. Our mission is to bridge the gap between clinical labels and real life, highlighting the overlaps and connections within the neurodivergent community.

Listen

How do I support my ADHD teen without turning help into surveillance?

A study finds 72 rare variants that disrupt microexon splicing in 2.5% of autistic participants—and the ADHD teen years reveal why "lazy" is the wrong label for executive-function gaps. - Microexon splicing and noncoding variants in autism - ADHD teen executive function and scaffolding - Medication adherence, diversion, and safe storage - Driving risks and readiness for teens with ADHD - Co-occurring conditions and girls with ADHD The answer isn't "try harder"—it's understanding the mechanism.

Living on the Spectrum — Show Notes

Overview: This episode begins with a Nature study reported by The Transmitter on machine-learning prediction of autism-linked variants that affect microexon splicing. Most of the episode focuses on ADHD in adolescence, drawing on three ADDitude articles about executive function, scaffolding, medication, diversion, driving, co-occurring conditions, and support. The ADDitude pieces are educational guidance rather than primary research; ADDitude states it does not provide medical advice, diagnosis, or treatment. The pieces range in date from 2020 to 2026.

Machine-learning model spots autism-linked variants that scramble splicing

Microexons are short DNA segments—typically 3 to 27 nucleotides long—that can be included in or left out of an RNA transcript during splicing. Because they are short, they can influence how proteins interact and function, especially in the brain. Previous work from Benjamin Blencowe’s team at the University of Toronto found altered microexon splicing in the brains of some autistic people, but it was unclear whether genetic variants were driving those changes, including variants in noncoding regions that do not make protein but contain regulatory instructions.

The new study built a machine-learning model using RNA-sequencing data from thousands of human and mouse tissue samples, including individual brain cells. It identified more than 1,500 previously unknown human microexons and more than 1,100 in mice, then applied the model to genetic data from 7,391 families across three large autism studies. It flagged 72 rare variants predicted to disrupt microexon splicing. In that dataset, those variants appeared in 2.5 percent of autistic participants and were not found in their non-autistic siblings. About 80 percent of carriers had no previously identified genetic explanation for their autism. Many variants were in genes involved in communication between neurons, including some already linked to autism. Three predicted variants were tested one at a time in human neurons, and each altered splicing by reducing inclusion of the microexon; other predicted variants were not tested that way.

Limits and context: the findings are associations, not a diagnostic test or proof that each variant causes autism on its own. The model is a prediction tool, and only three variants were tested experimentally. Species differences also matter: only about 12 percent of a subset of newly identified human microexons whose splicing differed between brain and other tissues had clear counterparts in mice, so this is not a simple mouse-to-human translation. Lilia Iakoucheva, who was not involved, called it a major advance because it moves from observing altered splicing to identifying variants that may contribute to it. Hyejung Won said it sheds light on noncoding variants but that identifying them is only a first step. Christopher Park said it shows how important splicing is in autism and how complex it can be; the article notes his institute is funded by The Transmitter’s parent organization. Open questions include which variants actually change neuronal function and whether microexons are especially vulnerable or part of a broader splicing story.

ADHD in Teens: Warning Signs & Treatments for Adolescents

Adolescence is a pressure point because demands rise while the brain is still developing. One article cites CDC figures that about 9.4 percent of U.S. children ages 2 to 17 have diagnosed ADHD. Symptoms are assessed relative to other teens their age and can look different by subtype—inattentive, hyperactive/impulsive, or combined—and by co-occurring conditions. Puberty can aggravate symptoms, academic load taxes executive functions, and the drive for independence can collide with impulsivity at milestones such as driving, sexual activity, drug and alcohol experimentation, and new friendships.

The articles describe ADHD as an impairment in the chemical dynamics of the brain, not a lack of effort or willpower. Executive skills—including response inhibition, working memory, emotional control, flexibility, sustained attention, task initiation, planning, organization, time management, and metacognition—on average do not fully develop until the early 20s, and the timeline is about three to five years longer for adolescents with ADHD. One article attributes to experts the claim that a young person with ADHD will not reach the emotional maturity of a neurotypical 21-year-old until their mid or late 30s; this is an expert claim, not a precise universal timetable. Executive function can be uneven and context-dependent, so a teen may function well in a favorite activity and still struggle with a school project. The articles note that teens with ADHD are often unfairly labeled lazy or oppositional because the difficulty is largely invisible.

The episode also referenced co-occurring anxiety and mood disorders, social isolation, and girls being missed—especially inattentive-type ADHD that may not be identified through elementary school. Teens may need self-advocacy skills for talking with teachers about accommodations, clinicians about treatment, and caregivers about mental and emotional health. School can be a source of shame, so teacher education and formal accommodation plans such as a 504 plan or an individualized education program matter. Support works better than criticism.

Teens with ADHD Need Scaffolds and Structure

This article argues for scaffolding rather than helicopter parenting: independence grows faster than executive-function skills in middle and high school, so structures should support the teen while they build skills, then step back. Examples include the teen making a to-do list, estimating time for each task, and tracking actual time to learn time budgeting. A paper planner is one option, but digital systems are fine if they work for that teen’s brain. A useful question is “Are you procrastinating or are you avoiding?” followed by talking through what and why.

Suggestions include a defined, quiet workspace; a get-started process that breaks tasks down; mind maps with sticky notes or flashcards for big writing assignments; and editing a first draft by moving sentences and paragraphs rather than scrapping it. The article also suggests a collaborative screen-use plan and keeping devices out of the bedroom at night because they interfere with sleep. School accommodations should be reviewed annually or twice annually as demands increase.

The article uses the phrase “pills and skills”: medication can help focus, but the teen still has to use that focus to practice skills. Medication is framed as one component, not a cure-all. Because independence can disrupt medication adherence, parents may need to monitor the schedule closely, discuss concerns openly, and involve the clinician in any changes.

4 Hazards of Teen ADHD — and Ways to Avert Them

The episode described this as the Dr. Timothy Wilens article and discussed several hazards it covers. On medication, less than half of teens receiving treatment say they want to continue medication because of side effects such as appetite loss and sleep problems, and because of stigma. Research estimates cited include that up to 20 percent of youth have used stimulants nonmedically and that up to 85 percent of those who misuse obtain them from teens with ADHD who have a prescription. The article recommends safe storage rather than a medicine cabinet, especially in college or boarding school. It reports that 25 percent of middle- and high-school students and 50 percent of college students with ADHD were approached in the past year to sell, trade, or give away their stimulant medication. Many adolescents are not aware of the legal, financial, and health consequences. Immediate-release formulations are more likely to be misused than extended-release ones, something for prescribers to weigh when appropriate.

On driving, a 2019 Children’s Hospital of Philadelphia study published in Pediatrics found drivers with ADHD had a 62 percent higher rate of injury crashes and a 109 percent higher rate of alcohol-related crashes than neurotypical counterparts. The article also cites National Highway Traffic Safety Administration figures: teens with ADHD are two to four times more likely to be in an automobile accident, four times more likely to be at fault, up to six times more likely to get speeding tickets, and six to eight times more likely to have suspended licenses. Some teens with ADHD are very careful drivers, while others are not ready; high impulsivity and emotionality may signal that a teen is not ready for that responsibility. Simply delaying the driving age to 18 does not appear to remedy crash risk, because many state laws designed to protect new drivers—such as phone-use penalties and passenger limits—do not apply to drivers 18 and older. The article recommends minimizing distractions such as cell phones and says higher accident rates improve dramatically when young people with ADHD receive effective ADHD treatment, though treatment is one factor, not a guarantee.

On substance use, the episode noted that about half of young adults with ADHD report recreational drug use, versus just over 30 percent of the neurotypical group, and about 70 percent of teens with ADHD identify as smokers, versus less than 40 percent of teens without ADHD. Early stimulant treatment is linked in long-term studies to lower risk of cigarette smoking and substance use disorders, but this is an association, not proof of causation.

Podcast Transcript

Aaron: Welcome to Living on the Spectrum. I'm Aaron, and with me is Jamie. Today we're starting with a new genetics study about autism and microexons, then we're going to spend most of the episode on ADHD in the teenage years—executive function, scaffolding, driving, medication, and what support looks like without turning a family into a surveillance operation. Jamie, the microexon paper was published in Nature and reported by The Transmitter in November 2026. Can you start with the basics? What is a microexon, and why does splicing matter?

Jamie: A microexon is a very short piece of DNA—typically three to 27 nucleotides long—that can be included in or left out of an RNA transcript. That inclusion or exclusion is splicing. Because these pieces are short, they can influence how proteins interact and function, especially in the brain. Previous work from Benjamin Blencowe's team at the University of Toronto had found altered microexon splicing in the brains of some autistic people, but it wasn't clear whether genetic variants were driving those changes—including variants in noncoding regions that don't make protein but contain regulatory instructions.

Aaron: So the new study is trying to connect a genetic variant to a splicing change?

Jamie: Exactly. They built a machine-learning model using existing RNA-sequencing data from thousands of human and mouse tissue samples, including individual brain cells, and looked at the DNA sequences around microexons to learn what features influence splicing. They identified more than 1,500 previously unknown human microexons and over 1,100 in mice. Then they applied the model to genetic data from 7,391 families across three large autism studies.

Aaron: And what did it find?

Jamie: It flagged 72 rare variants predicted to disrupt microexon splicing. In that dataset, those variants showed up in 2.5 percent of autistic participants and were not found in their non-autistic siblings. About 80 percent of the carriers had no previously identified genetic explanation for their autism. Many of the variants were in genes involved in communication between neurons, including some already linked to autism. The team tested three of the predicted variants, one at a time, in human neurons, and each altered splicing—reducing inclusion of the microexon. The other predicted variants were not tested that way.

Aaron: That sounds significant, but I want to be careful. Does this mean they found a cause of autism for 2.5 percent of autistic people?

Jamie: I'd phrase it more cautiously. These are rare variants predicted to disrupt splicing, and they were more common in autistic participants than in their non-autistic siblings in this dataset. That's an association, and the functional testing supports the idea that at least some of these variants do affect splicing. But it doesn't mean each variant causes autism on its own, and it isn't a diagnostic test. Lilia Iakoucheva, who wasn't involved, called it a major advance because it moves from observing altered splicing to identifying variants that may contribute to it. Hyejung Won said it sheds light on noncoding variants but that identifying them is only a first step. Christopher Park said it shows how important splicing is in autism and how complex it can be—the article notes his institute is funded by The Transmitter's parent organization. The next questions are which variants actually change neuronal function, and whether microexons are especially vulnerable or just part of a broader splicing story.

Aaron: The "no previously identified genetic explanation" piece is what I keep thinking about. In this study, about 80 percent of the carriers had no previously identified genetic explanation for their autism. That suggests an underappreciated source of variation—Blencowe called it that—but it's still research-grade, not something a family can ask for yet.

Jamie: Right. The model is a prediction tool; only three variants were tested experimentally. There are also species differences—only about 12 percent of a subset of newly identified human microexons whose splicing differed between brain and other tissues had clear counterparts in mice—so this isn't a simple mouse-to-human translation. It's a promising way to investigate noncoding regions, not a finished clinical story.

Aaron: Let's shift to the ADHD teen articles. We have three ADDitude pieces—one broad overview, one on scaffolding, and one from Dr. Timothy Wilens. They're educational guidance, not primary research, and ADDitude says it doesn't provide medical advice, diagnosis, or treatment. The dates range from 2020 to 2026. Jamie, why is adolescence such a pressure point for ADHD?

Jamie: Because the demands jump at the same time the brain is still developing. The CDC figures cited in one article put diagnosed ADHD at about 9.4 percent of U.S. children ages 2 to 17. Symptoms are assessed relative to other teens their age, and they can look different by subtype—inattentive, hyperactive/impulsive, or combined—and by co-occurring conditions. Puberty can aggravate symptoms, academic load taxes executive functions, and the drive for independence can collide with impulsivity at milestones like driving, sexual activity, drug and alcohol experimentation, and new friendships.

Aaron: And the articles are clear that this isn't a willpower problem.

Jamie: Yes. One article describes ADHD as an impairment in the chemical dynamics of the brain, not a lack of effort. On average, executive skills—things like response inhibition, working memory, emotional control, flexibility, sustained attention, task initiation, planning, organization, time management, and metacognition—don't fully develop until the early 20s, and the timeline is about three to five years longer for adolescents with ADHD. One article also attributes to experts the claim that a young person with ADHD will not reach the emotional maturity of a neurotypical 21-year-old until their mid or late 30s. That's an expert claim, not a precise universal timetable for every person, but it explains why a teen can look capable in a favorite activity and still struggle with a school project.

Aaron: That "capable in a favorite activity" thing is real. A kid can run a complicated video game or sport and then forget three homework assignments. The article says that confuses parents, physicians, and psychologists.

Jamie: Exactly. It's not that executive function is absent; it's uneven and context-dependent. And the article notes that teens with ADHD are often unfairly labeled lazy or oppositional because the difficulty is largely invisible.

Aaron: So what does support look like? The scaffolding article is explicitly arguing against helicopter parenting.

Jamie: Yes. It says independence grows faster than executive-function skills in middle and high school, so the goal is scaffolding—structures that support the teen while they build the skill, then step back. Practical examples: the teen makes a to-do list, estimates time for each task, and tracks actual time to learn to budget time. A paper planner is one option, but digital systems are fine if they work for that teen's brain. There's a great question to ask: "Are you procrastinating or are you avoiding?"—and then talk through what and why. They suggest a defined, quiet workspace and a get-started process that breaks tasks down. For big writing assignments, a mind map with sticky notes or flashcards, and editing a first draft by moving sentences and paragraphs rather than scrapping it. They also suggest a collaborative screen-use plan and keeping devices out of the bedroom at night because they interfere with sleep. And school accommodations should be reviewed annually or twice annually as demands increase.

Aaron: I like that the teen is doing the estimating and tracking, not the parent doing it for them. The article also has the phrase "pills and skills"—medication can help focus, but the teen still has to use that focus to practice skills.

Jamie: Right. The articles frame medication as one component, not a cure-all. The scaffolding article says independence can disrupt medication adherence, so parents may need to monitor the schedule closely and discuss concerns openly—and to involve the clinician in any changes. One article notes that less than half of teens receiving treatment say they want to continue medication because of side effects like appetite loss and sleep problems, and because of stigma. Another article cites research estimates that up to 20 percent of youth have used stimulants nonmedically, and that a majority—up to 85 percent—of those who misuse obtain them from teens with ADHD who have a prescription. That article recommends safe storage rather than a medicine cabinet, especially in college or boarding school. And one article reports that 25 percent of middle- and high-school students and 50 percent of college students with ADHD were approached in the past year to sell, trade, or give away their stimulant medication.

Aaron: That's a conversation many families don't have. It's not just "don't share your meds"—it's that there are legal, financial, and health consequences, and teens may be approached by other students.

Jamie: Yes, and the article says many adolescents aren't aware of those consequences. It also notes that immediate-release formulations are more likely to be misused than extended-release ones, which is something for prescribers to weigh when appropriate. But the bigger point is that medication diversion is common enough that families should be able to talk about it without shame.

Aaron: What about driving? That's the one where the risk is immediate.

Jamie: The 2019 Children's Hospital of Philadelphia study published in Pediatrics found drivers with ADHD had a 62 percent higher rate of injury crashes and a 109 percent higher rate of alcohol-related crashes than neurotypical counterparts. The article also cites National Highway Traffic Safety Administration figures: teens with ADHD are two to four times more likely to be in an automobile accident, four times more likely to be at fault, up to six times more likely to get speeding tickets, and six to eight times more likely to have suspended licenses. But it's not uniform—some teens with ADHD are very careful drivers, while others aren't ready. High impulsivity and emotionality may be a signal that a teen isn't ready for that responsibility. And simply delaying the driving age to 18 doesn't appear to remedy crash risk, because many state laws designed to protect new drivers—like phone-use penalties and passenger limits—don't apply to drivers 18 and older.

Aaron: So the question isn't "does the teen have ADHD, yes or no," it's "what supports does this particular teen need to drive safely, and are they ready yet?"

Jamie: That's a good translation. The article also recommends minimizing distractions like cell phones, and it says higher accident rates improve dramatically when young people with ADHD receive effective ADHD treatment—though that's about treatment as one factor, not a guarantee.

Aaron: The broader ADHD articles also flag substance use, anxiety and mood disorders, social isolation, and girls being missed. Should we touch on those?

Jamie: Briefly, because they're part of the everyday picture. One article says about half of young adults with ADHD report recreational drug use, versus just over 30 percent of the neurotypical group. About 70 percent of teens with ADHD identify as smokers, versus less than 40 percent of teens without ADHD. It notes that early stimulant treatment is linked in long-term studies to lower risk of cigarette smoking and substance use disorders—but that's an association, not proof of causation. Anxiety and mood disorders are common co-occurring conditions, and treatment should address both ADHD and the co-occurring condition. Socially, teens with ADHD may have fewer friends and more isolation, and the article notes they may give overly optimistic appraisals of their own social functioning—so a parent's perspective can help, without being dismissive. For girls, inattentive-type ADHD may be missed through elementary school; girls may appear less symptomatic and internalize their problems. School can be a source of shame, so teacher education matters—and so do formal school accommodation plans, like a 504 plan or an individualized education program. The articles also emphasize that teens need self-advocacy skills: talking with teachers about accommodations, with clinicians about treatment, and with caregivers about mental and emotional health. Support works better than criticism.

Aaron: The thread I hear across both halves of the episode is that the mechanism is often invisible—whether it's a genetic variant that scrambles splicing or an executive-function gap that looks like laziness. And in both cases, the answer isn't "try harder" or "assume the worst." It's better information, better support, and humility about what we don't know yet.

Jamie: I'd agree with that. The genetics study is a research advance, not a verdict about any one person. The ADHD guidance is educational, not a prescription for any one family. The through-line is that labels and mechanisms are useful when they help us understand what support makes sense—and less useful when they become a judgment.

Aaron: That's a good place to land. Thanks for listening to Living on the Spectrum. We'll put links to the original articles on the episode page, including the Nature study and the ADDitude pieces. Take care.

References

How do I support my ADHD teen without turning help into surveillance? · Living on the Spectrum